Target intelligence / Profile preview

Avian Influenza Virus Type A Subtype H9N2 (H9N2)

Target
H9N2
Molecular classification
Virus, RNA virus, Hemagglutinin, Neuraminidase
01

Overview

Avian influenza virus type A subtype H9N2 (A/H9N2) is a low pathogenic avian influenza (LPAI) virus that primarily infects birds but can also infect mammals, including humans. It possesses a segmented RNA genome encoding key proteins like hemagglutinin (HA) and neuraminidase (NA). H9N2 exhibits significant genetic diversity and has zoonotic potential due to adaptations that enhance binding to human-like receptors. While typically causing mild respiratory illness in humans, its role as a gene donor for emergent zoonotic strains warrants continued monitoring.

Other names
A/H9N2H9N2 influenza virus
02

Mechanism of action

Neuraminidase inhibitors block the release of virus from infected cells. M2 inhibitors block the M2 proton channel, preventing viral uncoating.

03

Biological functions

Viral replicationHost cell entryViral assemblyImmune evasion
04

Disease associations

Avian influenzaZoonotic infectionRespiratory illness
05

Safety considerations

Antiviral resistanceZoonotic transmissionPandemic potentialReassortment with other influenza virusesLimited efficacy of M2 inhibitors due to widespread resistance
06

Interacting drugs

Neuraminidase inhibitors (e.g., Oseltamivir, Zanamivir)

1 more in the full profile.

07

Biomarkers

Viral load (RT-qPCR)Antibody titersHA mutations (e.g., Leu226)Receptor binding affinity

Beyond the preview

Go deeper on Avian Influenza Virus Type A Subtype H9N2 (H9N2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Avian Influenza Virus Type A Subtype H9N2 (H9N2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call